New Year Sale: Save Up to 25% on MembershipsNew Year Sale: Save Up to 25% on MembershipsNew Year Sale: Save Up to 25% on MembershipsNew Year Sale: Save Up to 25% on MembershipsNew Year Sale: Save Up to 25% on MembershipsNew Year Sale: Save Up to 25% on Memberships
Targeted Fat Loss | Metabolic Activation | Body Sculpting | Weight-Loss Optimization
AOD-9604 is a next-generation fat-loss peptide derived from the active lipolytic fragment of human growth hormone, engineered specifically to stimulate fat breakdown without affecting blood sugar, growth hormone levels, or muscle mass.
At Sundrata Clinic in Summerlin, Las Vegas, medical-grade AOD-9604 therapy is used to target stubborn subcutaneous fat, enhance metabolic fat utilization, and refine body contours, making it an ideal adjunct to GLP-1 programs and post-weight-loss body optimization.
This therapy is ideal for patients who are losing weight but want more precise fat reduction and body sculpting—without hormonal side effects.
Medical professionals at Sundrata Clinic integrate Metabolic fat-burning injection into precision weight-loss and body-recomposition protocols.
What Is AOD-9604?
AOD-9604 is a synthetic peptide derived from amino acids 176–191 of human growth hormone—the region responsible for fat metabolism (lipolysis).
Unlike full growth hormone or GH-stimulating peptides:
It does not increase growth hormone levels
It does not affect cortisol, insulin, or blood suga
It does not cause muscle growth or hormonal disruption
Instead, AOD-9604 works by:
Stimulating lipolysis (fat breakdown)
Inhibiting lipogenesis (fat storage)
Increasing fat utilization as an energy source
This makes AOD-9604 particularly effective for stubborn fat areas that are resistant to diet, exercise, and even GLP-1 medications. Patients in Las Vegas choose AOD-9604 Peptide Therapy for targeted fat loss and body sculpting without affecting hormones.
Benefits of Glycine Therapy
Targets Stubborn Subcutaneous Fat
Helps reduce fat in common problem areas such as abdomen, flanks, hips, thighs, and arms.
Enhances Fat Metabolism Without Hormonal Effects
Supports fat loss without impacting growth hormone or insulin levels.
Preserves Lean Muscle Mass
Promotes fat loss without muscle breakdown.
Complements GLP-1 Weight-Loss Programs
Improves body composition and contour during rapid weight loss.
Supports Body Sculpting & Refinement
Ideal for patients near goal weight seeking improved definition.
Low Side-Effect Profile
Well-tolerated and non-stimulatory.
Supports Metabolic Efficiency
Encourages the body to preferentially burn fat for energy.
Why Choose AOD-9604 at Sundrata Clinic?
At Sundrata Clinic, AOD-9604 is prescribed and monitored by licensed medical professionals and integrated into precision body-recomposition protocols, including:
Our approach focuses on safe, targeted fat reduction with measurable body-composition improvements, not extreme or unsustainable weight loss. Our supervised metabolic fat-burning injection program improves fat utilization, preserves lean muscle, and enhances body contours.
What AOD-9604 Helps Improve
AOD-9604 Peptide Therapy targets abdominal fat, love handles, thigh and hip fat, and subcutaneous fat resistant to diet and exercise.
No. It is a fat-metabolism peptide that does not affect growth hormone or insulin levels.
Will it cause muscle gain or hormone changes?
No. It selectively targets fat metabolism and preserves lean mass.
When will I see results?
Fat-loss and contour changes typically become noticeable over 4–8 weeks, depending on protocol and lifestyle factors.
Can AOD-9604 be combined with GLP-1 therapy?
Yes. This is one of the most effective combinations for body recomposition and post-weight-loss refinement.
Sculpt Smarter. Lose Fat Strategically.
AOD-9604 Therapy at Sundrata Clinic delivers precision fat-loss support without hormonal disruption, making it an ideal solution for targeted body sculpting and weight-loss optimization.
Sundrata Clinic’s programs use AOD-9604 Peptide Therapy to deliver safe, non-hormonal fat-loss support and precise body sculpting.